Peptide vaccine with glucopyranosyl lipid A–stable oil-in-water emulsion for patients with resected melanoma

We tested the safety and immunogenicity of a novel vaccine in patients with resected high-risk melanoma. HLA-A2-positive patients with resected Stage II–IV melanoma were randomized to receive up to three vaccinations of melanoma-associated peptide (MART-1a) combined with a stable oil-in-water emulsi...

Ausführliche Beschreibung